The effect of atypical versus typical antipsychotics on tardive dyskinesia: A naturalistic study

European Archives of Psychiatry and Clinical Neuroscience

Volumn 257, Issue 3, 2007, Pages 169-172

  De Leon, Jose ^a,b  

^a Eastern State Hospital   (United States)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Atypical antipsychotics; Case control study; Tardive dyskinesia; Typical antipsychotics

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CRITERION VARIABLE; DRUG EFFICACY; DRUG EXPOSURE; FEMALE; HUMAN; MALE; MENTAL DISEASE; PRIORITY JOURNAL; SAMPLE (STATISTICS); TARDIVE DYSKINESIA;

ADULT; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; ODDS RATIO;

EID: 34247117050     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-006-0705-z     Document Type: Article

References (10)

1. Correll CU, Leucht S, Kane JM (2004) Lower risk for tardive dyskinesia associated with second-generation antipsychotics: A systematic review of 1-year studies. Am J Psychiatry 161:414-425
2. de Leon J, Susce MT, Pan RM, Fairchild M, Koch W, Wedlund PJ (2005) Polymorphic variations in GSTM1, GSTT1, PgP, CYP2D6, CYP3A5, and dopamine D2 and D3 receptors and their association with tardive dyskinesia in severe mental illness. J Clin Psychopharmacol 25:448-456
3. Dolder CR, Jeste DV (2003) Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients. Biol Psychiatry 53:1142-1145
4. Lee PE, Sykora K, Gill S, Mamdani M, Marras C, Anderson GM, Shulman KI, Stukel T, Normand S-L, Rochon PA (2005) Antipsychotic medications and drug-induced movement disorders other than parkinsonism: a population-based cohort study in older adults. J Am Geriatr Soc 53:1374-1379
5. Leucht S, Pitschel-Walz G, Abraham D, Kissling W (1999) Efficacy and extrapyramidal side-effects of new antipsychotics olanzapine, quetiapine, risperidone, and sertrindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trails. Schizophr Res 35:51-68
6. Nasrallah HA (2006) Focus on lower risk of tardive dyskinesia with atypical antipsychotics. Ann Clin Psychiatry 18:57-62
7. Markham-Abedi C, McNeely C, de Leon J (2006) Ziprasidoneinduced catatonia symptoms (letter). J Neuropsychiatr Clinical Neurosci (in press)
8. Pierre JM (2006) Extrapyramidal symptoms with atypical antipsychotics. Incidence, prevention and management. Drug Safety 28:191-208
9. Rochon PA, Stukel TA, Sykora K, Gill S, Garfinkel S, Anderson GM, Normand SL, Mamdani M, Lee PE, Li P, Bronskill SE, Marras C, Gurwitz JH (2005) Atypical antipsychotics and parkinsonism. Arch Intern Med 165:1882-1888
10. Schooler NR, Kane JM (1982) Research diagnoses for tardive dyskinesia (letter). Arch Gen Psychiatry 39:486-487